J. B. Chemicals & Pharmaceuticals Limited Stock price NSE India S.E.
Equities
JBCHEPHARM
INE572A01036
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,650 INR | +0.46% | +1.93% | +1.58% |
Sales 2024 * | 35.04B 420M | Sales 2025 * | 40.65B 488M | Capitalization | 256B 3.07B |
---|---|---|---|---|---|
Net income 2024 * | 5.67B 68.08M | Net income 2025 * | 7.08B 84.95M | EV / Sales 2024 * | 7.35 x |
Net Debt 2024 * | 1.62B 19.45M | Net cash position 2025 * | 4.3B 51.55M | EV / Sales 2025 * | 6.19 x |
P/E ratio 2024 * |
42.4
x | P/E ratio 2025 * |
33.9
x | Employees | 5,095 |
Yield 2024 * |
0.67% | Yield 2025 * |
0.79% | Free-Float | 45.81% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | +0.46% | ||
1 week | +1.93% | ||
Current month | +5.67% | ||
1 month | +3.14% | ||
3 months | +3.11% | ||
6 months | +17.14% | ||
Current year | +1.58% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 20-10-04 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 58 | 20-08-30 | |
Akshay Tanna
BRD | Director/Board Member | 41 | Nov. 06 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 21-02-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1,650 | +0.46% | 147,335 |
24-03-27 | 1,643 | +1.66% | 239,628 |
24-03-26 | 1,616 | -0.54% | 165,067 |
24-03-22 | 1,625 | +0.34% | 75,585 |
24-03-21 | 1,619 | +2.02% | 169,047 |
Delayed Quote NSE India S.E., March 28, 2024 at 08:02 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock J. B. Chemicals & Pharmaceuticals Limited
- Stock J. B. Chemicals & Pharmaceuticals Limited - NSE India S.E.